Topic: Myriad

Supreme Court Remands Myriad Following Rejection of Prometheus Patents

by on

When a unanimous Supreme Court earlier this month rejected Prometheus’ claims that isolated DNA sequences are patentable (see Mayo v. Prometheus: SCOTUS Issues Landmark IP Law Opinion), many wondered if the diagnostic testing patents held by Myriad Genetics would meet a similar fate. It took less than one week to get the answer. On March… Read more »

Myriad Genetics Ruling That DNA Is Patent-Eligible

by on

We’re seeing significant interest in the Myriad Genetics case, Association for Molecular Pathology v. U.S. Patent and Trademark Office, following the July 29, 2011, Court of Appeals for the Federal Circuit ruling that isolated DNA are patent-eligible subject matter. We’ll continue to update this reading list as additional commentary and analysis comes in: A Non-infringing… Read more »

Browse All Topics